Locomotion Changes in Methamphetamine and Amphetamine Withdrawal: a Systematic Review

Overview

Journal Front Pharmacol

Date 2024 Aug 1

PMID 39086393

Authors

Jaya Kumar

Isa Naina Mohamed

Rashidi Mohamed

Azizah Ugusman

Mustapha Muzaimi

Wael Mohamed

Mohamad Fairuz Yahaya

Seong Lin Teoh

Mohammad Rahim Kamaluddin

Hafizah Abdul Hamid

Muhammad Zulfadli Mehat

Prem Kumar Shanmugam

Affiliations

Soon will be listed here.

Abstract

Despite extensive preclinical research over the years, a significant gap remains in our understanding of the specific effects of methamphetamine (METH) and amphetamine (AMPH) withdrawal. Understanding these differences could be pivotal to unveiling the unique pathophysiology underlying each stimulant. This may facilitate the development of targeted and effective treatment strategies tailored to the specific characteristics of each substance. Following PRISMA guidelines, this systematic review was conducted to examine alterations in spontaneous locomotor activity, specifically horizontal activity, in animals experiencing withdrawal from extended and repeated administration of AMPH or METH. Original articles were retrieved from four electronic databases, supplemented by a review of the references cited in the published papers. A total of thirty-one full-length articles (n = 31) were incorporated in the analysis. The results indicated that six studies documented a significant increase in horizontal activity among animals, seven studies reported decreased locomotion, and eighteen studies (8 AMPH; 10 METH) reported no significant alterations in the animals' locomotor activity. Studies reporting heightened locomotion mainly employed mice undergoing withdrawal from METH, studies reporting diminished locomotion predominantly involved rats undergoing withdrawal from AMPH, and studies reporting no significant changes in horizontal activity employed both rats and mice (12 rats; 6 mice). Drug characteristics, routes of administration, animal models, dosage regimens, duration, and assessment timing seem to influence the observed outcomes. Despite more than 50% of papers enlisted in this review indicate no significant changes in the locomotion during the stimulant withdrawal, the unique reactions of animals to withdrawal from METH and AMPH reported by some underscore the need for a more nuanced understanding of stimulant withdrawal.

References

Szumlinski K, Lominac K, Campbell R, Cohen M, Fultz E, Brown C . Methamphetamine Addiction Vulnerability: The Glutamate, the Bad, and the Ugly. Biol Psychiatry. 2016; 81(11):959-970. PMC: 5391296. DOI: 10.1016/j.biopsych.2016.10.005. View

Wright S, Zanos P, Georgiou P, Yoo J, Ledent C, Hourani S . A critical role of striatal A2A R-mGlu5 R interactions in modulating the psychomotor and drug-seeking effects of methamphetamine. Addict Biol. 2015; 21(4):811-25. DOI: 10.1111/adb.12259. View

Kitanaka J, Kitanaka N, Takemura M . Neurochemical consequences of dysphoric state during amphetamine withdrawal in animal models: a review. Neurochem Res. 2007; 33(1):204-19. DOI: 10.1007/s11064-007-9409-7. View

Eyerman D, Yamamoto B . A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem. 2007; 103(3):1219-27. DOI: 10.1111/j.1471-4159.2007.04837.x. View

Barnum C, Pace T, Hu F, Neigh G, Tansey M . Psychological stress in adolescent and adult mice increases neuroinflammation and attenuates the response to LPS challenge. J Neuroinflammation. 2012; 9:9. PMC: 3283491. DOI: 10.1186/1742-2094-9-9. View

Robinson T, Camp D . Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. Pharmacol Biochem Behav. 1987; 26(4):821-7. DOI: 10.1016/0091-3057(87)90616-2. View

Damghani F, Bigdeli I, Miladi-Gorji H, Fadaei A . Swimming exercise attenuates psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats. Iran J Basic Med Sci. 2016; 19(6):594-600. PMC: 4951597. View

Koltunowska D, Gibula-Bruzda E, Kotlinska J . The influence of ionotropic and metabotropic glutamate receptor ligands on anxiety-like effect of amphetamine withdrawal in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 45:242-9. DOI: 10.1016/j.pnpbp.2013.04.013. View

Shoblock J, Sullivan E, Maisonneuve I, Glick S . Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology (Berl). 2002; 165(4):359-69. DOI: 10.1007/s00213-002-1288-7. View

10.

Vuong S, Oliver H, Scholl J, Oliver K, Forster G . Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism. Behav Brain Res. 2009; 208(1):278-81. PMC: 2821976. DOI: 10.1016/j.bbr.2009.11.036. View

11.

Alavijeh M, Vaezi G, Khaksari M, Hojati V . Berberine hydrochloride attenuates voluntary methamphetamine consumption and anxiety-like behaviors via modulation of oxytocin receptors in methamphetamine addicted rats. Physiol Behav. 2019; 206:157-165. DOI: 10.1016/j.physbeh.2019.03.024. View

12.

Sharma A, Bazylianska V, Moszczynska A . Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine. Exp Neurol. 2021; 345:113811. DOI: 10.1016/j.expneurol.2021.113811. View

13.

Konig N, Bimpisidis Z, Dumas S, Wallen-Mackenzie A . Selective Knockout of the () Gene in Calbindin2/Calretinin-Positive Neurons Results in Profound Changes in Behavior and Response to Drugs of Abuse. Front Behav Neurosci. 2020; 14:578443. PMC: 7680758. DOI: 10.3389/fnbeh.2020.578443. View

14.

Pulvirenti L, Koob G . Lisuride reduces psychomotor retardation during withdrawal from chronic intravenous amphetamine self-administration in rats. Neuropsychopharmacology. 1993; 8(3):213-8. DOI: 10.1038/npp.1993.23. View

15.

Schindler C, Persico A, Uhl G, Goldberg S . Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions. Pharmacol Biochem Behav. 1994; 49(1):41-6. DOI: 10.1016/0091-3057(94)90454-5. View

16.

Mouton M, Harvey B, Cockeran M, Brink C . The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression. Metab Brain Dis. 2015; 31(1):63-74. DOI: 10.1007/s11011-015-9765-y. View

17.

Good R, Liang L, Patel M, Radcliffe R . Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling. Neurotoxicology. 2011; 32(6):751-9. PMC: 3236638. DOI: 10.1016/j.neuro.2011.07.005. View

18.

Hazani H, Naina Mohamed I, Muzaimi M, Mohamed W, Yahaya M, Teoh S . Goofballing of Opioid and Methamphetamine: The Science Behind the Deadly Cocktail. Front Pharmacol. 2022; 13:859563. PMC: 9021401. DOI: 10.3389/fphar.2022.859563. View

19.

Segal D, Kuczenski R . Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization. J Pharmacol Exp Ther. 1997; 282(2):561-73. View

20.

Richetto J, Feldon J, Riva M, Meyer U . Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in mice. Eur Neuropsychopharmacol. 2012; 23(2):160-70. DOI: 10.1016/j.euroneuro.2012.04.005. View